Search

Author/Creator Furuse, Junji

1. A Cross-Sectional Survey of Factors Influencing Patients' Attitudes to Cancer Treatment. Issue 1 (2020)

Authors:
Fukasawa, Yoko; Watanabe, Kiyotaka; Matsumoto, Satoko; Naruge, Daisuke; Hayashi, Kazuhiko; Furuse, Junji; Kawamura, Masafumi; Jinno, Hiromitsu; Sano, Keiji; Fukushima, Ryoji; Aruga, Etsuko; Hashiguchi, Yojiro; Tanaka, Atsushi; Seki, Nobuhiko
Journal:
Japan journal of medicine
Issue:
Volume 3:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class. (21st February 2018)

Authors:
Suzuki, Eiichiro; Kaneko, Shuichi; Okusaka, Takuji; Ikeda, Masafumi; Yamaguchi, Kensei; Sugimoto, Rie; Aramaki, Takeshi; Asagi, Akinori; Yasui, Kohichiroh; Sano, Keiji; Hosokawa, Ayumu; Kato, Naoya; Ishii, Hiroshi; Sato, Tosiya; Furuse, Junji
Journal:
Japanese journal of clinical oncology
Issue:
Volume 48:Number 4(2018)
Page Start:
317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia. Issue 23 (15th August 2019)

Authors:
Hamauchi, Satoshi; Furuse, Junji; Takano, Toshimi; Munemoto, Yoshinori; Furuya, Ken; Baba, Hideo; Takeuchi, Manabu; Choda, Yasuhiro; Higashiguchi, Takashi; Naito, Tateaki; Muro, Kei; Takayama, Koichi; Oyama, Shusuke; Takiguchi, Toru; Komura, Naoyuki; Tamura, Kazuo
Journal:
Cancer
Issue:
Volume 125:Issue 23(2019)
Page Start:
4294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index. Issue 10 (23rd February 2022)

Authors:
Naito, Tateaki; Uchino, Junji; Kojima, Toru; Matano, Yutaka; Minato, Koichi; Tanaka, Kentaro; Mizukami, Takuro; Atagi, Shinji; Higashiguchi, Takashi; Muro, Kei; Takayama, Koichi; Furuse, Junji; Morishima, Eiichiro; Takiguchi, Toru; Tamura, Kazuo
Journal:
Cancer
Issue:
Volume 128:Issue 10(2022)
Page Start:
2025
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407). (March 2023)

Authors:
Ozaka, Masato; Nakachi, Kohei; Kobayashi, Satoshi; Ohba, Akihiro; Imaoka, Hiroshi; Terashima, Takeshi; Ishii, Hiroshi; Mizusawa, Junki; Katayama, Hiroshi; Kataoka, Tomoko; Okusaka, Takuji; Ikeda, Masafumi; Sasahira, Naoki; Miwa, Haruo; Mizukoshi, Eishiro; Okano, Naohiro; Mizuno, Nobumasa; Yamamot...
Journal:
European journal of cancer
Issue:
Volume 181(2023)
Page Start:
135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). (15th February 2018)

Authors:
Nakachi, Kohei; Konishi, Masaru; Ikeda, Masafumi; Mizusawa, Junki; Eba, Junko; Okusaka, Takuji; Ishii, Hiroshi; Fukuda, Haruhiko; Furuse, Junji
Journal:
Japanese journal of clinical oncology
Issue:
Volume 48:Number 4(2018)
Page Start:
392
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy. (26th February 2021)

Authors:
Ueno, Makoto; Morizane, Chigusa; Furukawa, Masayuki; Sakai, Daisuke; Komatsu, Yoshito; Nakai, Yousuke; Tsuda, Masahiro; Ozaka, Masato; Mizuno, Nobumasa; Muto, Manabu; Fukutomi, Akira; Ikeda, Masafumi; Tsuji, Akihito; Katanuma, Akio; Moriwaki, Toshikazu; Kajiwara, Takeshi; Ishii, Hiroshi; Negoro, ...
Journal:
Cancer medicine
Issue:
Volume 10:Number 6(2021)
Page Start:
2088
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma. Issue 10 (26th August 2020)

Authors:
Kudo, Masatoshi; Morimoto, Manabu; Moriguchi, Michihisa; Izumi, Namiki; Takayama, Tetsuji; Yoshiji, Hitoshi; Hino, Keisuke; Oikawa, Takayoshi; Chiba, Tetsuhiro; Motomura, Kenta; Kato, Junko; Yasuchika, Kentaro; Ido, Akio; Sato, Takashi; Nakashima, Daisuke; Ueshima, Kazuomi; Ikeda, Masafumi; Okusa...
Journal:
Cancer science
Issue:
Volume 111:Issue 10(2020)
Page Start:
3759
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗